Ryuji Ohashi
Impact in
- Nephrology top 1%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
- Cancer Research top 10%
Papers in
- Nephrology 25
- Renal Diseases and Glomerulopathies 20
-
- Breast Lesions and Carcinomas 10
- Co-authors
- Hiroshi KitamuraNobuaki YamanakaQing YaoAkira ShimizuHong MuZenya NaitoYukinari MasudaYuichi Sugisaki
- Journals
- Pathology International (4 papers)Diagnostic Cytopathology (3 papers)Breast Cancer (3 papers)Journal of Clinical Biochemistry and Nutrition (2 papers)Oncology Reports (2 papers)
- Partner nations
- JapanUnited StatesIreland
In The Last Decade
Ryuji Ohashi
106 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 105
- Nephrology 423
- Cancer Research 240
- Transplantation 37
- Immunology 249
- Endocrinology, Diabetes and Metabolism 188
Countries citing papers authored by Ryuji Ohashi
This map shows the geographic impact of Ryuji Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuji Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuji Ohashi more than expected).
Fields of papers citing papers by Ryuji Ohashi
This network shows the impact of papers produced by Ryuji Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuji Ohashi. The network helps show where Ryuji Ohashi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryuji Ohashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 0 | |
| 14 | 2019 | 14 | |
| 15 | 2018 | 17 | |
| 16 | 2018 | 5 | |
| 17 | 2017 | 8 | |
| 18 | 2016 | 2 | |
| 19 | 2013 | 17 | |
| 20 | 2001 | 197 |
About Ryuji Ohashi
Ryuji Ohashi is a scholar working on Nephrology, Pathology and Forensic Medicine, Rheumatology, Dermatology and Cancer Research, having authored 119 papers that have together received 1.8k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (20 papers), Breast Lesions and Carcinomas (10 papers), Breast Cancer Treatment Studies (9 papers), Salivary Gland Tumors Diagnosis and Treatment (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Vasculitis and related conditions (8 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Cancer and Skin Lesions (7 papers). The work is most often cited by research in Nephrology (423 citations), Cancer Research (240 citations), Transplantation (37 citations), Immunology (249 citations) and Endocrinology, Diabetes and Metabolism (188 citations). Ryuji Ohashi has collaborated with scholars based in Japan, United States and Ireland. Frequent co-authors include Hiroshi Kitamura, Nobuaki Yamanaka, Qing Yao, Akira Shimizu, Hong Mu, Zenya Naito, Yukinari Masuda, Yuichi Sugisaki, Masamichi Ishizaki and Toshiyuki Ishiwata. Their work appears in journals such as Pathology International, Diagnostic Cytopathology, Breast Cancer, Journal of Clinical Biochemistry and Nutrition and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.